2018/0118(NLE)

Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures

Awaiting Parliament 1st reading / single reading / budget 1st stage

2018/0118(NLE) Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures
RoleCommitteeRapporteurShadows
Lead LIBE ŠKRIPEK Branislav (ECR) HORTEFEUX Brice (EPP), HEDH Anna (S&D), PAGAZAURTUNDÚA RUIZ Maite (ALDE), ANDERSON Martina (GUE/NGL)
Lead committee dossier: LIBE/8/13013
Subjects
Links

Activites

  • 2018/09/11 Vote in plenary scheduled
  • 2018/09/03 Committee report tabled for plenary, 1st reading/single reading
    • A8-0271/2018 summary
    • LIBE LIBE/8/13013 ŠKRIPEK Branislav ECR
  • 2018/08/30 Vote in committee, 1st reading/single reading
  • 2018/07/02 Committee referral announced in Parliament, 1st reading/single reading
  • 2018/06/11 Legislative proposal published
    • 09420/2018 summary
    • DG {u'url': u'http://ec.europa.eu/info/departments/migration-and-home-affairs_en', u'title': u'Migration and Home Affairs'}, AVRAMOPOULOS Dimitris
  • 2018/04/30 Initial legislative proposal published
    • COM(2018)0253 summary
    • DG {u'url': u'http://ec.europa.eu/info/departments/migration-and-home-affairs_en', u'title': u'Migration and Home Affairs'}, AVRAMOPOULOS Dimitris

Documents

  • Initial legislative proposal published: COM(2018)0253
  • Legislative proposal published: 09420/2018
  • Committee report tabled for plenary, 1st reading/single reading: A8-0271/2018

Votes

A8-0271/2018 - Branislav Škripek - Vote unique

2018/09/11
Position Total ALDE ECR EFDD ENF GUE/NGL NI PPE S&D Verts/ALE correctional
For 635 64 53 17 24 42 16 202 172 45 0
Against 11 0 0 1 6 1 3 0 0 0 0
Abstain 37 0 17 19 1 0 0 0 0 0 0

History

(these mark the time of scraping, not the official date of the change)

2018-09-12
activities/0/docs/0/text added
  • PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

    PROPOSED ACT: Council Implementing Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

    They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

    Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

    Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

    Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

    The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

    CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

activities/0/docs/0/type changed
Old
Legislative proposal published
New
Initial legislative proposal published
activities/0/type changed
Old
Legislative proposal published
New
Initial legislative proposal published
activities/1 added
date
2018-06-11
docs
  • url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC
    text
    • PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

      PROPOSED ACT: Council Implementing Decision.

      ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

      BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

      They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

      Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

      Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

      Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

      The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

      CONTENT: the draft Council implementing decision aims to subject the new psychoactive substances  N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide ('cyclopropylfentanyl') and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide ('methoxyacetylfentanyl') to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

    type
    Legislative proposal published
    title
    09420/2018
type
Legislative proposal published
body
EC
commission
  • DG
    Commissioner
    AVRAMOPOULOS Dimitris
activities/2 added
date
2018-07-02
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
  • body
    EP
    shadows
    responsible
    True
    committee
    LIBE
    date
    2018-06-20
    committee_full
    Civil Liberties, Justice and Home Affairs
    rapporteur
    • group
      ECR
      name
      ŠKRIPEK Branislav
activities/3 added
date
2018-08-30
body
EP
type
Vote in committee, 1st reading/single reading
committees
  • body
    EP
    shadows
    responsible
    True
    committee
    LIBE
    date
    2018-06-20
    committee_full
    Civil Liberties, Justice and Home Affairs
    rapporteur
    • group
      ECR
      name
      ŠKRIPEK Branislav
activities/4 added
body
EP
docs
  • url
    http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN
    text
    • The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Branislav ŠKRIPEK (ECR, SK) on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

      The committee recommended that Parliament approve the Council draft.

      The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

      The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

    type
    Committee report tabled for plenary, 1st reading/single reading
    title
    A8-0271/2018
type
Committee report tabled for plenary, 1st reading/single reading
committees
  • body
    EP
    shadows
    responsible
    True
    committee
    LIBE
    date
    2018-06-20
    committee_full
    Civil Liberties, Justice and Home Affairs
    rapporteur
    • group
      ECR
      name
      ŠKRIPEK Branislav
date
2018-09-03
activities/5 added
date
2018-09-11
body
EP
type
Vote in plenary scheduled
committees/0/date added 2018-06-20
committees/0/rapporteur added
  • group
    ECR
    name
    ŠKRIPEK Branislav
committees/0/shadows added
  • group
    EPP
    name
    HORTEFEUX Brice
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    PAGAZAURTUNDÚA RUIZ Maite
  • group
    GUE/NGL
    name
    ANDERSON Martina
procedure/Modified legal basis added Rules of Procedure EP 150
procedure/dossier_of_the_committee added LIBE/8/13013
procedure/stage_reached changed
Old
Preparatory phase in Parliament
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
2018-05-09

code AGPLv3.0+, data ODBLv1.0, site-content CC-By-Sa-3.0
© European Union, 2011 – Source: European Parliament